Search details
1.
PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients.
Pharmacol Res
; 163: 105241, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33049397
2.
Androgen receptor expression inversely correlates with histological grade and N stage in ER+/PgRlow male breast cancer.
Breast Cancer Res Treat
; 182(1): 55-65, 2020 Jul.
Article
in English
| MEDLINE | ID: mdl-32436149
3.
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.
J Cell Physiol
; 234(6): 7708-7717, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30536609
4.
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients.
Breast Cancer Res Treat
; 178(1): 57-62, 2019 Nov.
Article
in English
| MEDLINE | ID: mdl-31346846
5.
Alterations of Signaling Pathways Related to the Immune System in Breast Cancer: New Perspectives in Patient Management.
Int J Mol Sci
; 19(9)2018 Sep 12.
Article
in English
| MEDLINE | ID: mdl-30213113
6.
Recent Advances in Comprehending the Signaling Pathways Involved in the Progression of Breast Cancer.
Int J Mol Sci
; 18(11)2017 Nov 03.
Article
in English
| MEDLINE | ID: mdl-29099748
7.
Pharmacological Basis of Breast Cancer Resistance to Therapies - An Overview.
Anticancer Agents Med Chem
; 22(4): 760-774, 2022.
Article
in English
| MEDLINE | ID: mdl-34348634
8.
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients.
Clin Breast Cancer
; 20(1): e89-e98, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31378534
9.
ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer.
Front Oncol
; 9: 547, 2019.
Article
in English
| MEDLINE | ID: mdl-31297336
10.
Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Oncotarget
; 9(94): 36720-36721, 2018 11 30.
Article
in English
| MEDLINE | ID: mdl-30613355
11.
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Oncotarget
; 9(61): 31877-31887, 2018 08 07.
Article
in English
| MEDLINE | ID: mdl-30159129
12.
Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.
Oncotarget
; 9(77): 34639-34640, 2018 10 02.
Article
in English
| MEDLINE | ID: mdl-30349655
Results
1 -
12
de 12
1
Next >
>>